Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 19
Original Research
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,251 | Dovepress* | 2,093+ | 49 | 2,142 | |
PubMed Central* | 158 | 104 | 262 | ||
Totals | 2,251 | 153 | 2,404 | ||
*Since 11 January 2024 |
View citations on PubMed Central and Google Scholar